Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.

Fu L, Sheng JQ, Li XO, Jin P, Mu H, Han M, Huang JS, Sun ZQ, Li AQ, Wu ZT, Li SR.

Cell Oncol (Dordr). 2013 Jun;36(3):225-31. doi: 10.1007/s13402-013-0130-z. Epub 2013 May 3.

PMID:
23640085
2.
3.

Risk of pancreatic cancer in families with Lynch syndrome.

Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S.

JAMA. 2009 Oct 28;302(16):1790-5. doi: 10.1001/jama.2009.1529.

4.

Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.

Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, Vasen HF, Thomas HJ.

Gastroenterology. 2006 Jun;130(7):1995-2000.

PMID:
16762622
5.

The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.

Ketabi Z, Gerdes AM, Mosgaard B, Ladelund S, Bernstein I.

Gynecol Oncol. 2014 Jun;133(3):526-30. doi: 10.1016/j.ygyno.2014.03.012. Epub 2014 Mar 13.

PMID:
24631699
6.

Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations.

Hu P, Lee CW, Xu JP, Simien C, Fan CL, Tam M, Ramagli L, Brown BW, Lynch P, Frazier ML, Siciliano MJ, Coolbaugh-Murphy M.

Ann Clin Lab Sci. 2011 Fall;41(4):321-30.

PMID:
22166501
7.

Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.

Yamaguchi T, Furukawa Y, Nakamura Y, Matsubara N, Ishikawa H, Arai M, Tomita N, Tamura K, Sugano K, Ishioka C, Yoshida T, Moriya Y, Ishida H, Watanabe T, Sugihara K; HNPCC Registry and Genetic Testing Project of the Japanese Society for Cancer of the Colon and Rectum.

Jpn J Clin Oncol. 2015 Feb;45(2):153-9. doi: 10.1093/jjco/hyu190. Epub 2014 Nov 17.

PMID:
25404568
8.

Prediction of Lynch syndrome in consecutive patients with colorectal cancer.

Green RC, Parfrey PS, Woods MO, Younghusband HB.

J Natl Cancer Inst. 2009 Mar 4;101(5):331-40. doi: 10.1093/jnci/djn499. Epub 2009 Feb 24.

PMID:
19244167
9.

Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Casey MJ, Bewtra C, Lynch HT, Snyder C, Stacy M, Watson P.

Fam Cancer. 2013 Dec;12(4):719-40. doi: 10.1007/s10689-013-9651-x.

PMID:
23666231
10.

Hereditary prostate cancer as a feature of Lynch syndrome.

Bauer CM, Ray AM, Halstead-Nussloch BA, Dekker RG, Raymond VM, Gruber SB, Cooney KA.

Fam Cancer. 2011 Mar;10(1):37-42. doi: 10.1007/s10689-010-9388-8.

11.

Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation.

Lastella P, Patruno M, Forte G, Montanaro A, Di Gregorio C, Sabbà C, Suppressa P, Piepoli A, Panza A, Andriulli A, Resta N, Stella A.

Fam Cancer. 2011 Jun;10(2):285-95. doi: 10.1007/s10689-011-9419-0.

PMID:
21286823
12.

[Familial and genetic study in a large Chinese kindred with hereditary nonpolyposis colorectal cancer].

Li TG, Liu XP, Zheng D, Sun JC, Li J, Tan ZP, Qin ZQ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Apr;24(2):227-9. Chinese.

PMID:
17407090
13.

Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer.

Heinimann K, Scott RJ, Buerstedde JM, Weber W, Siebold K, Attenhofer M, Müller H, Dobbie Z.

Cancer. 1999 Jun 15;85(12):2512-8.

PMID:
10375096
14.

Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.

Weber TK, Conlon W, Petrelli NJ, Rodriguez-Bigas M, Keitz B, Pazik J, Farrell C, O'Malley L, Oshalim M, Abdo M, Anderson G, Stoler D, Yandell D.

Cancer Res. 1997 Sep 1;57(17):3798-803.

16.

Performance of Lynch syndrome predictive models in a multi-center US referral population.

Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, Kupfer SS, Terdiman J.

Am J Gastroenterol. 2011 Oct;106(10):1822-7; quiz 1828. doi: 10.1038/ajg.2011.200. Epub 2011 Jul 12.

17.

Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation?

Marcelis CL, van der Putten HW, Tops C, Lutgens LC, Moog U.

Fam Cancer. 2001;1(2):107-9.

PMID:
14574006
18.

Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.

Park JG, Vasen HF, Park KJ, Peltomaki P, Ponz de Leon M, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lynch HT.

Dis Colon Rectum. 1999 Jun;42(6):710-5; discussion 715-6.

PMID:
10378593
19.

Lynch syndrome: a pediatric perspective.

Huang SC, Durno CA, Erdman SH.

J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):144-52. doi: 10.1097/MPG.0000000000000179. Review.

PMID:
24051481
20.

Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.

Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J.

Am J Hum Genet. 2001 Jan;68(1):118-127. Epub 2000 Dec 7. Erratum in: Am J Hum Genet 2001 Feb;68(2):557.

Supplemental Content

Support Center